BioVersys AG (SWX:BIOV)
Switzerland · Delayed Price · Currency is CHF 26.50
-0.90 (-3.28%)
Last updated: Sep 10, 2026, 1:57 PM CET
BioVersys AG Market Cap
BioVersys AG has a market cap or net worth of 155.43 million as of September 11, 2026. Its market cap has decreased by -15.03% in one year.
Market Cap
155.43M
Enterprise Value
108.29M
Revenue
4.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.50
ChartMarket Cap Chart
Since February 6, 2025, BioVersys AG's market cap has decreased from 207.92M to 155.43M, a decrease of -25.25%. That is a compound annual growth rate of -16.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 155.43M | 8.93% |
| Dec 30, 2025 | 142.69M | -31.37% |
| Feb 6, 2025 | 207.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 5.94B |
| Idorsia | 1.32B |
| Basilea Pharmaceutica AG | 804.70M |
| Santhera Pharmaceuticals Holding AG | 248.37M |
| Newron Pharmaceuticals | 246.34M |
| Molecular Partners AG | 129.85M |
| Xlife Sciences AG | 83.82M |
| MindMaze Therapeutics Holding | 29.61M |